Tivicay
Product Images NDC 67296-1818

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Tivicay (NDC 67296-1818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3 Count (67296 1818 3)

Label for Tivicay 50 mg tablets, package of 3, NDC 67296-1818, Rx only. The label includes storage instructions to keep at controlled room temperature (20-25°C or 68-77°F). Manufacturer is GlaxoSmithKline, with distribution by RedPharm Drug, Inc. located in Eden Prairie, MN. The label also shows lot number TS4PX1 and expiration date 03/25.*

FDA Label Image

Dolutegravir Chemical Structure (Tivicay Spl Graphic 01)

Chemical structure of the active ingredient in Tivicay. The diagram depicts the molecular formula with labeled atoms and bonds representing the compound's specific chemical arrangement.*

FDA Label Image

Tivicay Pack (Tivicay Spl Graphic 02)

Illustration showing a bottle, a dosing cup, and a syringe with labeled parts including bottle, cup with volume markings in milliliters, and syringe consisting of tip, syringe body with milliliter graduations, and plunger. The image appears to guide measurement or administration of medication.*

FDA Label Image

Figure A (Tivicay Spl Graphic 03)

An instructional illustration showing a water volume guide for dissolving tablets. The guide correlates the number of tablets (1, 3, 4, 5, 6) with the required water volume (5 mL or 10 mL). To the right is a clear measuring cup marked with water volume graduations from 5 mL to 30 mL, with water being poured into it.*

FDA Label Image

Figure B And Figure C (Tivicay Spl Graphic 04)

An instructional illustration showing a hand holding a small measuring cup with volume markings from 5 mL to 30 mL. The right side demonstrates swirling the cup in a circular motion for 1 to 2 minutes, indicated by an orange arrow around the cup's top edge.*

FDA Label Image

Figure D (Tivicay Spl Graphic 05)

An instructional illustration showing a hand giving medicine to a child using a small cup, with the text 'Give the medicine to a child' above the image. The child is depicted in profile receiving the medicine.*

FDA Label Image

Figure E And Figure F (Tivicay Spl Graphic 06)

An instructional illustration showing how to give medicine to an infant using a syringe. The first part depicts drawing liquid medicine into the syringe, and the second shows administering the medicine into the infant's mouth.*

FDA Label Image

Figure G And Figure H (Tivicay Spl Graphic 07)

An instructional illustration showing two hands preparing medication for injection. The left panel depicts a hand peeling a protective cover from a needle or vial, while the right panel shows a hand drawing liquid into a syringe from a vial or container, with drops visible around the syringe tip.*

FDA Label Image

Tivicay Pd 5 mg 60 Count Carton (Tivicay Spl Graphic 08)

Tivicay PD (dolutegravir) Tablets for Oral Suspension 5 mg packaging label showing product name, strength, form, and usage warnings. The label includes dosage content per tablet, package contents of 60 tablets with an oral dosing syringe and dosing cup, and manufacturer branding by ViiV Healthcare. It warns that Tivicay and Tivicay PD are not interchangeable and highlights safety instructions regarding the membrane seal under the cap.*

FDA Label Image

Tivicay 10 mg 30 Count Label (Tivicay Spl Graphic 09)

Label for Tivicay (dolutegravir) tablets, 10 mg strength, showing packaging for 30 tablets. The label includes storage instructions, manufacturer information including ViiV Healthcare and GlaxoSmithKline logos, and a barcode. The label indicates the product is Rx only and displays the NDC 49702-226-13.*

FDA Label Image

Tivicay 25 mg Count Label (Tivicay Spl Graphic 10)

Tivicay (dolutegravir) 25 mg tablets label showing NDC 49702-227-13. The label states each film-coated tablet contains dolutegravir sodium equivalent to 25 mg of dolutegravir. The package contains 30 tablets. It is manufactured by GlaxoSmithKline for ViiV Healthcare, with storage information and a QR code.*

FDA Label Image

Tivicay 50 mg 30 Count Label (Tivicay Spl Graphic 11)

Tivicay 50 mg tablets label showing dolutegravir as the active ingredient. The label indicates it is a prescription product with NDC 49702-228-13. It contains 30 film-coated tablets, manufactured for ViiV Healthcare by GlaxoSmithKline in Japan. Storage instructions and a QR code are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.